Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome
Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021
$12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries
$12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries
HMD supplies first lot of 56 mn syringes to Covax facility
Covax facility has ordered 140 million KOJAK AD Syringes from HMD to be supplied between August and December 2020
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India
Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery
The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
SEC asks CDSCO to submit adverse event report of death during Umifenovir trial
It should include analysis of the ethics committee, investigator and sponsor etc., for review
Norway to distribute free COVID-19 vaccine to all its inhabitants
This would become part of the country’s national vaccination programme
Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy
Immuneel acquires exclusive license to CD19 CAR T product for the potential treatment of B cell malignancies for India
Vaibhav Karandikar is the new Chief Financial Officer of Sanofi India
Before joining Sanofi 13 years ago, Karandikar has worked with Sandoz India, Tata Power and Hindustan Ciba Geigy
J&J COVID-19 vaccine trial paused due to unexplained illness in participant
The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the…